Akums Drugs And Pharmaceuticals Ltd
NSE: AKUMS | BSE: 544222
₹535.25
₹3.05
(0.57%)
As on 27-May-2026IST
Market cap
₹8,431 Cr
Revenue (TTM)
₹4,359 Cr
P/E Ratio
33
P/B Ratio
2.5
Div. Yield
0.6 %
Quality Score
6/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹255 Cr
-
ROE
18.3 %
-
ROCE
17.8 %
-
Industry P/E
46.93
-
EV/EBITDA
10.5
-
Debt to Equity
0
-
Book Value
₹210.6
-
EPS
₹17.1
-
Face value
2
-
Shares outstanding
157,393,988
10 Years Aggregate
CFO
₹1,685.27 Cr
EBITDA
₹1,971.15 Cr
Net Profit
₹657.21 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Akums Drugs And Pharmaceuticals
| 18.1 | 4.1 | 11.0 | -8.0 | -- | -- | -- |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
|---|---|
|
Akums Drugs And Pharmaceuticals
| -28.4 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Akums Drugs And Pharmaceuticals
|
535.3 | 8,430.8 | 4,359.0 | 256.4 | 8.4 | 8.3 | 33 | 2.5 |
| 3,000.6 | 24,577.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69 | 14.9 | |
| 754.2 | 14,832.7 | 7,344.9 | 670.6 | 10.9 | 13.7 | 22 | 2.6 | |
| 428.8 | 16,406.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.5 | 4.2 | |
| 782.6 | 19,421.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 991.8 | 15,788.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.6 | 2.2 | |
| 1,791.1 | 20,554.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 174.2 | 23,155.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 460.4 | 18,574.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.7 | 3.8 | |
| 1,771.0 | 28,787.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 135.2 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All News
5 min read•By Hemkesh Khattar
About Akums Drugs And Pharmaceuticals
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets,... vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India. Read more
-
Incorporated
2004
-
Chairman
--
-
Managing Director
Sanjeev Jain
-
Headquarters
Delhi, Delhi
-
Website
Looking for more details about Akums Drugs And Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Akums Drugs And Pharmaceuticals
What is the current share price of Akums Drugs And Pharmaceuticals Ltd Today?
The share price of Akums Drugs And Pharmaceuticals Ltd is ₹535.25 (NSE) and ₹535.65 (BSE) as of 27-May-2026 IST. Akums Drugs And Pharmaceuticals Ltd has given a return of -8.02% in the last 1 years.
What is the current PB & PE ratio of Akums Drugs And Pharmaceuticals Ltd?
The P/E ratio of Akums Drugs And Pharmaceuticals Ltd is 33.04 times as on 27-May-2026, a 30 discount to its peers’ median range of 46.93 times.
The P/B ratio of Akums Drugs And Pharmaceuticals Ltd is 2.54 times as on 27-May-2026, a 35 discount to its peers’ median range of 3.88 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.49
|
2.38
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Akums Drugs And Pharmaceuticals Ltd?
The 52-week high and low of Akums Drugs And Pharmaceuticals Ltd are Rs 622.95 and Rs 409.30 as of 27-May-2026.
What is the market cap of Akums Drugs And Pharmaceuticals Ltd?
Akums Drugs And Pharmaceuticals Ltd has a market capitalisation of ₹ 8,431 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Akums Drugs And Pharmaceuticals Ltd?
Before investing in Akums Drugs And Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.